Skip to main content
Fig. 2 | BMC Cardiovascular Disorders

Fig. 2

From: Effect of Tadalafil on cardiac function and left ventricular dimensions in Duchenne muscular dystrophy: safety and cardiac MRI substudy results from a randomized, placebo-controlled trial

Fig. 2

Change from baseline to endpoint (Week 48) or last observation in left ventricular CMR parameters. Points represent the least squares (LS) mean change with standard error. End systolic volume (A), end diastolic volume (B), cardiac output (C), stroke volume (D), left ventricular mass (E), left ventricular ejection fraction (F). ETD = estimated treatment difference for the difference of tadalafil minus placebo with 95% confidence interval from an analysis of covariance (ANCOVA) with change from baseline as dependent variable, baseline value as covariate, and treatment as fixed effect

Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us